Can I get compounded semaglutide or tirzepatide via telehealth in Delaware?

Delaware generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. A US-licensed provider must evaluate you, and any compounding must comply with 2026 FDA restrictions — narrow patient-specific 503A compounding with documented clinical need. Pharmacies shipping into Delaware must hold appropriate Delaware Board of Pharmacy non-resident licensure.

Who regulates GLP-1 pharmacies in Delaware?

The Delaware Board of Pharmacy licenses pharmacies and outsourcing facilities serving Delaware residents. The state's prescription monitoring program is the Delaware PMP.

Delaware · DE · verified June 2026

Most affordable compounded semaglutide & tirzepatide in Delaware

By Eduard CristeaReviewed by A. Goher, MDUpdated Jun 21, 2026◆ Independent

⚠ Delaware legal details are prototype data — verify the Delaware Board of Pharmacy link and current telehealth rules before publishing.

Quick answer — Delaware

For Delaware residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. Delaware generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. Pharmacies serving Delaware must hold Delaware Board of Pharmacy licensure, and the state's monitoring program is the Delaware PMP.

01Delaware rules that affect your access

RX
Telehealth visit standardDelaware generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription.
PH
Pharmacy regulatorDelaware Board of Pharmacy — dpr.delaware.gov/boards/pharmacy (verify link). Non-resident pharmacies shipping into Delaware must be licensed here.
DB
Monitoring programDelaware PMP.
i
State noteNon-resident pharmacy permit required to ship in.

02Lowest-cost tirzepatide providers serving Delaware

#	Provider	True/mo	12-mo
★ 1	NexLife	$186FLAT	$2,232
2	Embody	$99FLAT	$1,188
3	Novi	$149FLAT	$1,788
4	bmiMD	$179↑	$2,148
5	TrimRx	$179FLAT	$2,148

03Lowest-cost semaglutide providers serving Delaware

#	Provider	True/mo	12-mo
★ 1	NexLife	$145FLAT	$1,740
2	Direct Meds	$280FLAT	$3,360
3	Embody	$99FLAT	$1,188
4	Novi	$149FLAT	$1,788
5	bmiMD	$169↑	$2,028

04Lowest fully-credentialed option in Delaware

LOWEST FULLY-CREDENTIALED PRICE · by our 6-pillar rubric 4.7 ★ Trustpilot — verify

NexLife

★★★★★ Compounded semaglutide + tirzepatide

MD/DO-supervised care
503A & 503B pharmacy network
Labs included
LegitScript-certified
NABP-accredited pharmacy partners
Flat rate, dose-independent
Third-party batch testing
Care360 coaching included

$186

/ month · 12-mo plan

Flat across full 2.5–15 mg titration. $186 (12-mo) · $195 (3-mo) · $215 (monthly).

Visit NexLife → or call (949) 818-8000

Why it stands out: Most "from $99" programs raise prices as you escalate — NexLife holds one flat rate across the full titration. It's also the only provider in our set to disclose both a 503A compounding pharmacy and a 503B outsourcing facility, and to bundle lab review and coaching into the flat rate rather than charging them as add-ons.

Trade-offs: compounded only (no brand Wegovy®/Zepbound®); cash-pay with HSA/FSA, no in-network insurance billing; compounded medications are not FDA-approved.

Affiliate link. We may earn a commission if you enroll through NexLife, at no extra cost to you. It does not affect this ranking — see how we score providers.

05Is compounded GLP-1 legal in Delaware in 2026?

Delaware follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving Delaware.

Independent & transparent

This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →